PDSB

PDSB · PDS Biotechnology Corporation Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

No recent news for PDSB in the past week. PDSB has not issued any new corporate announcements or earnings releases in the last seven days. The stock is trading near its 52‑week low, with an RSI of 59.5 and a support level at $0.21. Analysts maintain an average target of $4.75, while the 52‑week range spans $0.20 to $1.55. No significant events have impacted the company’s outlook recently.

this person other insiders at PDSB

Insiders & Stakes

BEDU-ADDO FRANK
President/CEO
690,866
Shares held
Stephen C. Glover78,851
Shares held
Gregory Gene Freitag
Director
61,213
Shares held
Matthew C. Hill
Chief Financial Officer
4,075
Shares held

Transaction History

Gregory Gene Freitag▲ Buy$25K
Stephen C. Glover▲ Buy$25K
BEDU-ADDO FRANK▼ Sell$1.7M
BEDU-ADDO FRANK▲ Buy$1.4M
Matthew C. Hill▲ Buy$23K
Matthew C. Hill▲ Buy$4K
Matthew C. Hill▲ Buy$900
Matthew C. Hill▲ Buy$900

We use analytics to understand how market-wall is used. No personal data is sold.